Sentence examples for multiple sclerosis trials from inspiring English sources

Coronado also expects results from its multiple sclerosis trials next year.

They conform to rates seen for placebo arms in relapsing remitting multiple sclerosis trials.

Such scales have been used both in amyotrophic lateral sclerosis trials and in multiple sclerosis trials for a long time.

He also received compensation through payments to his employer for perform central MRI analysis of multiple sclerosis trials from Biogen Idec, GlaxoSmithKline, Merck, and Novartis.

Further studies of diffusion tensor imaging and magnetization transfer imaging (Wang et al., 2012) will help refine MRI's role and feasibility for use in multicentre optic neuritis and multiple sclerosis trials.

Analogous to a central MRI reading centre, which has become the standard approach in multiple sclerosis trials, a central OCT reading centre would be responsible for training sites in standardized image acquisition procedures, developing case report forms, and deploying computerized retinal segmentation software.

A multiple sclerosis trial, in which 150 patients were treated for three months, showed about a 60percentt decrease in symptoms in patients receiving Neurodex compared with those getting a placebo.

"Some of my patients have had it and would suddenly start laughing in the middle of a funeral or church service," said Hillel Panitch, a professor of neurology at the University of Vermont, who presented the results of Avanir's multiple sclerosis trial at the recent meeting of the American Academy of Neurology.

Because IBM is predictably disabling and notoriously resistant to therapies, the encouraging results from this pilot study and the good tolerance of the drug, provide the impetus to consider a large placebo-controlled trial with repeated infusions to assess the long-term benefits keeping in mind the safety concerns raised in the recent multiple sclerosis trial (the CAMMS233 Trial, 2008).

Based on these observations, LCLA shows promise as a vision-related outcome for multiple sclerosis clinical trials and as an additional component test for the MSFC.

Historically, multiple sclerosis clinical trials have lacked sensitive, vision-specific outcome measures.